What does Ogi stand for?
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce the launch of its most recent cannabis 2.0 product Trailblazer Snax, a premium-quality, value-priced, cannabis-infused chocolate bar.
Where can I buy shares of Ogi?
Shares of OGI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Is the Ogi sector being supported?
Fifty-two week low for ACB, HEXO, CRON, CGC, TLRY and OGI among others. Sector is not being supported. I believe it’s a matter of time for it to recuperate. Been long for several years and still think OGI will be one of the leaders. The RSI was at 31 yesterday. Today it’s below 30. Way over sold. I bought more too. At these prices it’s a bargain.
What is organigram Holdings Inc (Orgi)?
Sign-up to receive the latest news and ratings for OrganiGram and its competitors with MarketBeat's FREE daily newsletter. OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. It focuses on producing cannabis for patients and adult recreational consumers. The firm's brands include Adult Recreational and Medical.
Is OGI stock a good buy?
Out of 9 analysts, 3 (33.33%) are recommending OGI as a Strong Buy, 2 (22.22%) are recommending OGI as a Buy, 4 (44.44%) are recommending OGI as a Hold, 0 (0%) are recommending OGI as a Sell, and 0 (0%) are recommending OGI as a Strong Sell. What is OGI's earnings growth forecast for 2022-2024?
Is organigram a Buy Sell or Hold?
OrganiGram has received a consensus rating of Buy. The company's average rating score is 2.67, and is based on 4 buy ratings, 2 hold ratings, and no sell ratings.
Does OGI stock pay dividends?
OGI does not currently pay a dividend.
Is OGI a US company?
The company was founded on July 5, 2010 and is headquartered in Moncton, Canada.
What is the future of Ogi stock?
OrganiGram Holdings Inc (NASDAQ:OGI) The 10 analysts offering 12-month price forecasts for OrganiGram Holdings Inc have a median target of 2.00, with a high estimate of 2.66 and a low estimate of 1.14. The median estimate represents a +84.78% increase from the last price of 1.08.
Is Ogi a buy Zacks?
How good is it? See rankings and related performance below. The VGM Score are a complementary set of indicators to use alongside the Zacks Rank....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return2Buy18.15%3Hold9.70%4Sell5.35%5Strong Sell2.45%2 more rows
When did Ogi go public?
January 5, 2012OGI stock went public on January 5, 2012 and ended the day at $0.29. The stock has since gained 1,000%. So, a $500 investment in OGI just after its IPO is currently worth $5,000. This also means that OGI stock gained a monstrous 3,800% between January 2012 and May 2019.
How many outstanding shares does Ogi have?
Share StatisticsAvg Vol (3 month) 33.95MShares Outstanding 5313.69MImplied Shares Outstanding 6N/AFloat 8249.18M% Held by Insiders 118.66%7 more rows
What is Ogi?
Ogi (or Akamu) is a fermented cereal pudding and popular street food from Nigeria, typically made from maize, sorghum, or millet. Traditionally, the grains are soaked in water for up to three days, before wet-milling and sieving to remove husks.
Should I buy or sell OrganiGram stock right now?
7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OrganiGram in the last twelve months. There are currently 3 hold ratings a...
What is OrganiGram's stock price forecast for 2022?
7 equities research analysts have issued twelve-month target prices for OrganiGram's shares. Their forecasts range from $2.25 to $5.30. On average,...
How has OrganiGram's stock performed in 2022?
OrganiGram's stock was trading at $1.75 at the start of the year. Since then, OGI stock has decreased by 40.0% and is now trading at $1.05. View t...
When is OrganiGram's next earnings date?
OrganiGram is scheduled to release its next quarterly earnings announcement on Tuesday, July 12th 2022. View our earnings forecast for OrganiGram .
How were OrganiGram's earnings last quarter?
OrganiGram Holdings Inc. (NASDAQ:OGI) announced its quarterly earnings results on Tuesday, April, 12th. The company reported ($0.02) earnings per s...
Who are OrganiGram's key executives?
OrganiGram's management team includes the following people: Mr. Derrick W. West CPA , CPA, (CA), Chief Financial Officer (Age 55, Pay $241.72k)...
Who are some of OrganiGram's key competitors?
Some companies that are related to OrganiGram include BELLUS Health (BLUSF) , Madrigal Pharmaceuticals (MDGL) , Lyell Immunopharma (LYEL) , Cry...
What other stocks do shareholders of OrganiGram own?
Based on aggregate information from My MarketBeat watchlists, some companies that other OrganiGram investors own include KushCo (KSHB) , (CGC) ,...
What is OrganiGram's stock symbol?
OrganiGram trades on the NASDAQ under the ticker symbol "OGI."
What is the rating of Organigram?
What is the official website of Organigram?
OrganiGram has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 2 buy ratings, 6 hold ratings, and no sell ratings.
Where is Organigram based?
The official website for OrganiGram is www.organigram.ca.
Is Organigram a hold?
It focuses on producing cannabis for patients and adult recreational consumers. The firm's brands include Adult Recreational and Medical. The company was founded on July 5, 2010 and is headquartered in Moncton, Canada.
Does Organigram pay dividends?
Wall Street analysts have given OrganiGram a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but OrganiGram wasn't one of them.
Nasdaq Global Select
OrganiGram does not currently pay a dividend.
Environmental, Social, and Governance Rating
Based in Atlantic Canada, OrganiGram sells medical cannabis both online and via phone to individuals and physicians. The company operates five healing centers for post-traumatic stress disorder treatment, chronic pain, trauma therapy, and medical cannabis as an alternative medicine.
Business Summary
"B" score indicates good relative ESG performance and an above-average degree of transparency in reporting material ESG data publicly and privately. Scores range from AAA to D.
Organigram Reports Highest Quarterly Net Revenue Ever In Q1, Remains Among Top Canadian Cannabis LPs
Based in Atlantic Canada, OrganiGram sells medical cannabis both online and via phone to individuals and physicians. The company operates five healing centers for post-traumatic stress disorder treatment, chronic pain, trauma therapy, and medical cannabis as an alternative medicine.
Benzinga Interview: Organigram CEO Beena Goldenberg Discusses Company Performance And Canadian Cannabis Market
Cannabis company Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) announced its results for the first quarter ended November 30, 2021.
Premium Research for OGI
OrganiGram Holdings Inc (NASDAQ: OGI) (TSE: OGI) CEO Beena Goldenberg recently spoke with Benzinga to discuss the company's ongoing growth and Q2 success.
Company Summary
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Why Canopy Growth, Hexo, and OrganiGram Are Slumping Today
Organigram Holdings Inc. is a licensed producer of cannabis and cannabis-derived products primarily in Canada, through a wholly owned subsidiary. Organigram Holdings Inc. is based in Moncton, Canada.
Despite Market Headwinds, Organigram Is Making Progress Toward Its Goals
Canadian marijuana stocks are reversing course Monday after last week's industrywide surge higher.
Why Marijuana Stocks Are Smoking Hot Today
Like most marijuana stocks, Organigram (NASDAQ: OGI) has underperformed the market in recent years, but in its most recent fiscal first quarter, the company showed off strong growth and a narrowing loss on the bottom line. In this episode of "Beat and Raise" recorded on Jan.
